Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen

PLoS Neglected Tropical Diseases

Volumn 9, Issue 12, 2015, Pages

  Gonçalves, Antônio J S ^a   Oliveira, Edson R A ^a   Costa, Simone M ^a   Paes, Marciano V ^a   Silva, Juliana F A ^a   Azevedo, Adriana S ^a   Mantuano Barradas, Marcio ^a   Nogueira, Ana Cristina M A ^a   Almeida, Cecília J ^a   Alves, Ada M B ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA VACCINE; GAMMA INTERFERON; NONSTRUCTURAL PROTEIN 1; TISSUE PLASMINOGEN ACTIVATOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DENGUE; DENV2 NS1 GENE; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; GENE; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; SURVIVAL RATE; VIRUS LOAD;

EID: 84953300844     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004277     Document Type: Article

References (70)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution and burden of dengue. Nature 496–504.
2. Gubler D.J, (2012) The economic burden of dengue. Am J Trop Med Hyg 86: 743. doi: 10.4269/ajtmh.2012.12-0157 22556068
3. Martina BE, Koraka P, Osterhaus AD, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564–581. doi: 10.1128/CMR.00035-09 19822889
4. Chuansumrit A, Chaiyaratana W, (2014) Hemostatic derangement in dengue hemorrhagic fever. Thromb Res 133: 10–16. doi: 10.1016/j.thromres.2013.09.028 24120237
5. Lindebach BD, Rice CM, Fields B. N., Knipe D. M., M. Howley P., . (2001) Flavirididae: The viruses and their replication. In: Fields Virology. (Eds.) 4th ed. 991–1024.
6. Flamand M, Megret F, Mathieu M, Lepault J, Rey FA, et al. (1999) Dengue Virus Type 1 Nonstructural Glycoprotein NS1 Is Secreted from Mammalian Cells as a Soluble Hexamer in a Glycosylation-Dependent. Fashion J Virol 73: 6104–6110. 10364366
7. Jacobs MG, Robinson PL, Bletchly C, Mackenzie JM, Young PR, (2000) Dengue virus nonstructural protein 1 is expressed in a glycosyl-phosphatidylinositol-linked form that is capable of signal transduction. Faseb J 14: 1603–1610. 10928995
8. Somnuke P, Hauhart RE, Atkinson JP, Diamond MS, Avirutnan P, (2011) N-linked glycosylation of dengue virus NS1 protein modulates secretion cell-surface expression hexamer stability and interactions with human complement. Virology 413: 253–264. doi: 10.1016/j.virol.2011.02.022 21429549
9. Young PR, Hilditch PA, Blechly C, Halloran W, (2000) An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 38: 1053–1057. 10698995
10. Alcon-LePoder S, Sivard P, Drouet MT, Talarmin A, Rice C, et al. (2006) Secretion of flaviviral nonstructural protein NS1: from diagnosis to pathogenesis. Novartis Found Symp 277: 233–247. 17319166
11. Muller DA, Young PR, (2013) The flavivirus NS1 protein: molecular and structural biology immunology role in pathogenesis and application as a diagnostic biomarker. Antiviral Res 98:192–208. doi: 10.1016/j.antiviral.2013.03.008 23523765
12. Mackenzie JM, Jones MK, Young PR, (1996) Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220: 232–240. 8659120
13. Lindenbach BD, Rice CM, (1997) Trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 71: 9608–9617. 9371625
14. Lindenbach BD, Rice CM, (1999) Genetic interaction of flavivirus nonstructural proteins NS1 and NS4A as a determinant of replicase function. J Virol 73: 4611–4621. 10233920
15. Westaway EG, Mackenzie JM, Kenney MT, Jones MK, Khromykh AA, (1997) Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA and of NS2B with NS3 in virus-induced membrane structures. J Virol 71: 6650–6661. 9261387
16. Khromykh AA, Sedlak PL, Westaway EG, . (2000) Cis- and trans-acting elements in flavivirus RNA replication. J Virol 74: 3253–3263. 10708442
17. Chung KM, Liszewski MK, Nybakken G, Davis AE, Townsend R R, et al. (2006) West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H. Proc Natl Acad Sci USA 103: 19111–19116. 17132743
18. Kuno G, Vorndam AV, Gubler DJ, Gomez I, (1990) Study of anti-dengue NS1 antibody by Western blot. J Med Virol 32: 102–108. 2149144
19. Churdboonchart V, Bhamarapravati N, Peampramprecha S, Sirinavin S, (1991) Antibodies against dengue viral proteins in primary and secondary dengue hemorrhagic fever. Am J Trop Med Hyg 44: 481–493. 2063952
20. Shu PY, Chen LK, Chang SF, Yueh YY, Chow L, et al. (2000) Dengue NS1-specific antibody responses: isotype distribution and serotyping in patients with Dengue fever and Dengue hemorrhagic fever. J Med Virol 62: 224–232. 11002252
21. Schlesinger JJ, Brandriss MW, Walsh E, (1987) Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus nonstructural glycoprotein NS1. J Gen Virol 68: 853–857. 3819700
22. Henchal EA, Henchal LS, Schlesinger JJ, (1988) Synergistic interaction of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus. J Gen Virol 69: 2101–2107. 3404125
23. Costa SM, Paes MV, Barreto DF, Pinhão AT, Barth OM, et al. (2006). Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine 24: 195–205 16122850
24. Costa SM, Azevedo AS, Paes MV, Sarges FS, Freire MS, et al. (2007) DNA vaccines against dengue virus based on the ns1 gene: The influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice. Virology 358: 413–423. 17020777
25. Wu SF, Liao CL, Lin YL, Yeh CT, Chen LK, et al. (2003) Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine Against dengue 2 virus in mice. Vaccine 21: 3919–3929. 12922127
26. Wan SW, Lu YT, Huang CH, Lin CF, Anderson R, et al. (2014)Protection against denguevirus infection in mice by administration of antibodies against modified nonstructural protein 1. PLoS One 9: e92495 doi: 10.1371/journal.pone.0092495 24658118
27. Falconar AK, (1997) The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clottingintegrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol 142: 897–916. 9191856
28. Falconar AK, (2007) Antibody responses are generated to immunodominant ELK/KLE type motifs on the nonstructural-1 glycoprotein during live dengue vírus infections in mice and humans: implications for diagnosis pathogenesis and vaccine design. Clin Vaccine Immunol 5: 493–504.
29. Liu J, Chiu C, Chen Y, Wu H, (2011) Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue vírus. J Biol Chem 11: 9726–9736.
30. Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, et al. (2002) Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): arginine glycine aspartic acid structural mimicry within the dengue viral NS1 antigen. J Infect Dis 186: 743–751. 12198607
31. Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, et al. (2003) Antibodies from dengue patient sera cross-react with endothelial cells and induce damage. J Med Virol 69: 82–90. 12436482
32. Lin C, Chiu S, Hsiao Y, Wan S, LeiH et al. (2005) Expression of Cytokine chemokineand adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein. J Immunol 174: 395–403. 15611263
33. Oishi K, Inoue S, Cinco MT, Dimano EM, Alera MT, et al. (2003) Correlation between increased platelet-associated IgG and thrombocytopenia in secondary dengue virus infections. J Med Virol 71: 259–64. 12938201
34. Sun DS, King CC, Huang HS, Shih YL, Lee CC, et al. (2007) Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost 5: 2291–2299. 17958746
35. Halstead SB, Nimmannitya S, Cohen SN, (1970) Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered. Yale J BiolMed 42: 311–328.
36. Mongkolsapaya J, Dejnirattisai W, Xu XN, Vasanawathana S, Tangthawornchaikul N, et al. (2003) Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med 9: 921–927. 12808447
37. Kinney RM, Huang CYH, (2001) Development of new vaccines against dengue fever and Japanese encephalitis. Intervirology 44: 176–197. 11509879
38. Whitehead SS, Blaney JE, Durbin AP, Brian RM, (2007) Prospects for a dengue virus vaccine. Nat Rev Microbiol 5: 518–528. 17558424
39. Heinz FX, Stiasny K, (2012) Flaviviruses and flavivirus vaccines. Vaccine 30: 4301–4306. doi: 10.1016/j.vaccine.2011.09.114 22682286
40. Ishiakawa T, Yamanaka A, Konishi E, (2014) A review of successful flavivirus vaccines and the problems with those flavivirus for which vaccines are not yet available. Vaccine 32: 1326–1337. doi: 10.1016/j.vaccine.2014.01.040 24486372
41. Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, et al. (2012) Protective efficacy of the recombinant live-attenuated CYD tetravalent dengue vaccine in Thai schoolchildren: a randomized controlled phase 2b trial. Lancet 380: 1559–1567. doi: 10.1016/S0140-6736(12)61428-7 22975340
42. Paes MV, Lenzi HL, Nogueira ACM, Nuovo GJ, Pinhao AT, et al. (2009) Hepatic damage associated with dengue-2 virus replication in liver cells of BALB/c mice. Lab Invest 89: 1140–1151. doi: 10.1038/labinvest.2009.83 19721415
43. Erhardt W, Hebestedt A, Aschenbrenner G, Pichotka B, Blümel G, . (1984). A comparative study with various anesthetics in mice (pentobarbitone ketamine-xylazine carfentanyl-etomidate). Res Exp Med 184: 159–169.
44. Amorim JH, Porchia BFMM, Balan A, Cavalcante RCM, Costa SM, et al. (2010) Refolded dengue virus type 2 NS1 protein expressed in Escherichia coli preserves structural and immunological properties of the native protein. J Virol Methods 167: 186–192. doi: 10.1016/j.jviromet.2010.04.003 20399232
45. Gao G, Wang Q, Dai Z, Calcedo R, Sun X, et al. (2008) Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes. Hum Gene Ther 19: 927–936. doi: 10.1089/hum.2008.011 18788905
46. Martin DL, Tarleton RL, (2005) Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent. J Immunol 174: 1594–1601. 15661921
47. Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, et al. (2001) Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF. Virology 290: 74–82. 11883007
48. Danko JR, Beckett CG, Porter KR, (2011) Development of dengue DNA vaccines. Vaccine 29: 7261–7266. doi: 10.1016/j.vaccine.2011.07.019 21777640
49. Azevedo AS, Gonçalves AJ, Archer Freire MS, Galler R, et al. (2013) The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue. PLoS One 8: e58357. doi: 10.1371/journal.pone.0058357 23472186
50. Halstead SB, O'Rourke EJ, (1977) Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J Exp Med 146: 201–217. 406347
51. Halstead SB, Dengue (2007) Lancet 370: 1644–1652. 17993365
52. Murphy BR, Whitehead SS, (2011) Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol 29: 587–619. doi: 10.1146/annurev-immunol-031210-101315 21219187
53. Lin CF, Wan SW, Chen MC, Lin SC, Cheng CC, et al. (2008) Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model. Lab. Invest 88: 1079–1089. doi: 10.1038/labinvest.2008.70 18679379
54. Boyle JS, Koniaras C, Lew AM, (1997) Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. Int Immunol 9: 1897–1906. 9466317
55. Inchauspe G, Vitvitski L, Major M, Jung G, Spengler U, et al. (1997) Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. DNA Cell Biol 16: 185–195. 9052739
56. Alves AMB, Lásaro MO, Almeida DF, Ferreira LC, (1999) New vaccine strategies against enterotoxigenic Escherichia coli. I: DNA vaccines against the CFA/I fimbrial adhesin. Braz J Med Biol Res 32: 223–229. 10347758
57. Schlesinger JJ, Brandriss M W, Cropp CB, Monath TP, (1986) Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol 60: 1153–1155. 3783816
58. Li Y, Lu D.C.P, Duong V, Yu Y, Deubel V, (2012) Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model Virol J 9: 135. doi: 10.1186/1743-422X-9-135 22828206
59. Mladinich KM, Piaskowski SM, Rudersdorf R, Eernisse CM, Weisgrau KL, et al. (2012) Dengue virus-specific CD4+ and CD8+ T lymphocytes target NS1, NS3 and NS5 in infected Indian rhesus macaques. Immunogenetics 64: 111–121 doi: 10.1007/s00251-011-0566-0 21881953
60. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, et al. (2009). A protective role for dengue virus-specific CD8+ T cells. J Immunol 182: 4865–4873. doi: 10.4049/jimmunol.0801974 19342665
61. Yauch LE, Prestwood TR, May M, Morar MM, Zellweger RM, et al. (2010) CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 185: 5405–5416. doi: 10.4049/jimmunol.1001709 20870934
62. Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, et al. (1998) Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses. Arch Virol 143: 997–1003. 9645204
63. Caufour OS, Motta MC, Yamamura AM, Vazquez S, Ferreira et al. (2001) Construction characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses. Virus Res 79: 1–14. 11551641
64. Valdes I, Bernardo L, Gil L, Pavon A, Lazo L, et al. (2009) A novel fusion protein domain III-capsid from dengue-2 in a highly aggregated form induces a functional immune response and protection in mice. Virology 394: 249–258. doi: 10.1016/j.virol.2009.08.029 19783271
65. Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, et al. (2010) Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys. Vaccine 28: 2705–2715. doi: 10.1016/j.vaccine.2010.01.022 20097152
66. Azevedo AS, Yamamura AM, Freire MS, Trindade GF, Bonaldo M, et al. (2011) DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One 6: e20528. doi: 10.1371/journal.pone.0020528 21779317
67. Costa SM, Yorio AP, Gonçalves AJ, Vidale MM, Costa EC, et al. (2011)Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines. PLoS One 6: e25685. doi: 10.1371/journal.pone.0025685 22031819
68. Miagostovich MP, Ramos RG, Nicol AF, Nogueira RMP, Cuzzimaya T, et al. (1997) Retrospective study on dengue fatal cases. Clin Neuropathol 16: 204–208. 9266146
69. Ramos C, Sánchez G, Pando RH, Baquera J, Hernández D, et al. (1998) Dengue virus in the brain of a fatal case of hemorrhagic dengue fever. J Neurovirol 4: 465–468. 9718141
70. Soares CN, Cabral-Castro MJ, Peralta JM, de Freitas MR, Zalis M, et al. (2011) Review of the etiologies of viral meningitis and encephalitis in a dengue endemic region. J Neurol Sci 303: 75–79. doi: 10.1016/j.jns.2011.01.012 21292281